Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
42.63
+0.68 (+1.62%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Calm Markets Day
May 07, 2021
Despite seriously disappointing April jobless numbers, markets are gaining all the same.
Via
Talk Markets
Biden Administration Backs Waiving IP Protections For COVID-19 Vaccines, Pharma Industry Rebukes Move
May 06, 2021
The closely watched issue of patent rights for COVID-19 vaccines garnered headlines again as the Biden administration came out in favor of a proposal at the World Trade...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Were Hedge Funds Right About Piling Into American Express Company?
May 03, 2021
Is American Express Company ready to rally soon? The best stock pickers were turning bullish. The number of bullish hedge fund positions rose by 12 in recent months. American Express Company was in 60...
Via
Talk Markets
Novavax Next In List To Start Testing Its COVID-19 Shot In Adolescents
May 03, 2021
Novavax Inc (NASDAQ: NVAX) has initiated a pediatric expansion of its Phase 3 PREVENT-19 trial for NVX-CoV2373, its COVID-19 vaccine candidate. The additional...
Via
Benzinga
Exposures
COVID-19
Analyzing The Price Action In GlaxoSmithKline Stock Today
April 15, 2021
GlaxoSmithKline's Stock Price And Volume Action GlaxoSmithKline (NYSE:GSK...
Via
Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2021
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...
Via
Benzinga
Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days
April 30, 2021
Emergent BioSolutions Inc (NYSE: EBS) said it hopes to respond to U.S. regulators within days on how to resolve the problems at its Baltimore plant, which have forced...
Via
Benzinga
Exposures
Product Safety
Pfizer-BioNTech Bullish On COVID-19 Vaccine Trial Results In Infants By September: Reuters
April 29, 2021
BioNTech SE's (NASDAQ: BNTX) CEO Ugur Sahin says the company, along with its partner Pfizer Inc (NYSE: PFE), could have data from trials testing the...
Via
Benzinga
Exposures
COVID-19
2 Undervalued Pharmaceutical Stocks to Buy Now
April 29, 2021
These two high-dividend stocks might be great additions to your portfolio.
Via
The Motley Fool
GlaxoSmithKline plc (GSK) Q1 2021 Earnings Call Transcript
April 28, 2021
GSK earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
A Heavy News Day And Crypto
April 28, 2021
Israeli TEVA reported Q1 sales which missed forecasts at $4 bn, leading to a 2.6% drop in its price earlier today.
Via
Talk Markets
Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran
April 28, 2021
Sanofi SA (NASDAQ: SNY) stock climbed after its Q1 earnings beat earnings expectations and stuck to its full-year guidance, as well as reported progress on its...
Via
Benzinga
Topics
Earnings
Exposures
Financial
GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook
April 28, 2021
GlaxoSmithKline Plc Q1 revenue fell 18% in the first quarter, as the COVID-19 vaccination program delayed sales of its Shingrix shot for shingles.
Via
Talk Markets
Exposures
COVID-19
GlaxoSmithKline Q1 Profit, Sales Decline As COVID-19 Vaccination Delay Other Treatments; Backs 2021 Outlook
April 28, 2021
GlaxoSmithKline Plc (NYSE: GSK) Q1 revenue fell 18% in the first quarter, as the COVID-19 vaccination program delayed sales of its Shingrix shot for shingles....
Via
Benzinga
Exposures
COVID-19
US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses
April 27, 2021
The United States will start to share up to 60 million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine doses with other countries as they become...
Via
Benzinga
Exposures
COVID-19
Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine
April 26, 2021
As the demand for mRNA-based COVID-19 vaccines persists, Sanofi SA (NASDAQ: SNY) has entered an agreement with Moderna Inc (NASDAQ: MRNA)...
Via
Benzinga
Exposures
COVID-19
Friday Market Report
April 23, 2021
Schlumberger Ltd of Curação today reported on its Q1 results which were good.
Via
Talk Markets
Oscar Telecast Sells Out Advertising Slots Despite Historically Low Award Show Ratings
April 23, 2021
ABC has sold out the available advertising slots for Sunday’s Academy Awards telecast, even though ratings on entertainment awards shows have been plummeting and this...
Via
Benzinga
1 Cheap Pharmaceutical Stock to Buy in 2021
April 23, 2021
GlaxoSmithKline presents a great opportunity for investors this year.
Via
The Motley Fool
GlaxoSmithKline's Immunotherapy For Endometrial Cancer Wins FDA Approval
April 22, 2021
The FDA has granted accelerated approval to GlaxoSmithKline plc's (NYSE: GSK) Jemperli (dostarlimab) for endometrial cancer. The approval covers...
Via
Benzinga
Exposures
Product Safety
Robots
April 19, 2021
Teva is suffering from fear of the legal risks of its opioid misselling which is overriding good news of its newer drugs.
Via
Talk Markets
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Benzinga's Bulls And Bears Of The Week: Alphabet, Coinbase, GE, Quantumscape, Tesla And More
April 17, 2021
Benzinga has examined the prospects for many investor favorite stocks
Via
Benzinga
Happy News Day
April 15, 2021
The stock markets are in clover because March retail sales hit 9.8% according to the Department of Commerce.
Via
Talk Markets
Why GlaxoSmithKline Stock Jumped Today
April 15, 2021
An activist investor is reportedly building a significant position in the drugmaker.
Via
The Motley Fool
BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
April 15, 2021
GlaxoSmithKline plc (NYSE: GSK) announced the termination of the Phase II and Phase III studies of feladilimab, its ICOS receptor agonist in head and neck cancer. This comes as a...
Via
Benzinga
GlaxoSmithKline Surges On Report Activist Investor Takes 'Significant' Stake
April 15, 2021
GlaxoSmithKline gained Thursday on a report Elliott Management has built a "significant" stake in the pharmaceutical giant. GSK stock gapped up.
Via
Investor's Business Daily
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Apr. 15, 2021: DELL, AEO, GSK, UNH, INO
April 15, 2021
Today's 5 Stock Ideas: Dell Technologies (DELL) - Shares were up about 8% Thursday morning after the company announced the planned spin-off of VMware. American...
Via
Benzinga
UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
April 14, 2021
Researchers said that a U.K. study of using different Covid-19 vaccines in two-dose inoculations is now expanded to include vaccines made by Moderna Inc (NASDAQ: ...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.